Skip to main content
Erschienen in: Osteoporosis International 1/2014

01.01.2014 | Original Article

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study

verfasst von: C. L. Gregson, E. M. Dennison, J. E. Compston, S. Adami, J. D. Adachi, F. A. Anderson Jr, S. Boonen, R. Chapurlat, A. Díez-Pérez, S. L. Greenspan, F. H. Hooven, A. Z. LaCroix, J. W. Nieves, J. C. Netelenbos, J. Pfeilschifter, M. Rossini, C. Roux, K. G. Saag, S. Silverman, E. S. Siris, N. B. Watts, A. Wyman, C. Cooper, for the GLOW Investigators

Erschienen in: Osteoporosis International | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Summary

Accurate patient risk perception of adverse health events promotes greater autonomy over, and motivation towards, health-related lifestyles.

Introduction

We compared self-perceived fracture risk and 3-year incident fracture rates in postmenopausal women with a range of morbidities in the Global Longitudinal study of Osteoporosis in Women (GLOW).

Methods

GLOW is an international cohort study involving 723 physician practices across ten countries (Europe, North America, Australasia); 60,393 women aged ≥55 years completed baseline questionnaires detailing medical history and self-perceived fracture risk. Annual follow-up determined self-reported incident fractures.

Results

In total 2,945/43,832 (6.8 %) sustained an incident fracture over 3 years. All morbidities were associated with increased fracture rates, particularly Parkinson's disease (hazard ratio [HR]; 95 % confidence interval [CI], 3.89; 2.78–5.44), multiple sclerosis (2.70; 1.90–3.83), cerebrovascular events (2.02; 1.67–2.46), and rheumatoid arthritis (2.15; 1.53–3.04) (all p < 0.001). Most individuals perceived their fracture risk as similar to (46 %) or lower than (36 %) women of the same age. While increased self-perceived fracture risk was strongly associated with incident fracture rates, only 29 % experiencing a fracture perceived their risk as increased. Under-appreciation of fracture risk occurred for all morbidities, including neurological disease, where women with low self-perceived fracture risk had a fracture HR 2.39 (CI 1.74–3.29) compared with women without morbidities.

Conclusions

Postmenopausal women with morbidities tend to under-appreciate their risk, including in the context of neurological diseases, where fracture rates were highest in this cohort. This has important implications for health education, particularly among women with Parkinson's disease, multiple sclerosis, or cerebrovascular disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Beaglehole R, Bonita R, Horton R et al (2011) Priority actions for the non-communicable disease crisis. Lancet 377:1438–1447PubMedCrossRef Beaglehole R, Bonita R, Horton R et al (2011) Priority actions for the non-communicable disease crisis. Lancet 377:1438–1447PubMedCrossRef
3.
Zurück zum Zitat van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517–522PubMedCrossRef van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517–522PubMedCrossRef
4.
Zurück zum Zitat Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767PubMedCrossRef Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767PubMedCrossRef
5.
Zurück zum Zitat Chen JS, Hogan C, Lyubomirsky G, Sambrook PN (2011) Women with cardiovascular disease have increased risk of osteoporotic fracture. Calcif Tissue Int 88:9–15PubMedCrossRef Chen JS, Hogan C, Lyubomirsky G, Sambrook PN (2011) Women with cardiovascular disease have increased risk of osteoporotic fracture. Calcif Tissue Int 88:9–15PubMedCrossRef
6.
Zurück zum Zitat Drake MT, Murad MH, Mauck KF et al (2012) Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:1861–1870PubMedCrossRef Drake MT, Murad MH, Mauck KF et al (2012) Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:1861–1870PubMedCrossRef
7.
Zurück zum Zitat Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505PubMedCrossRef Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505PubMedCrossRef
8.
Zurück zum Zitat Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis. Osteoporos Int 18:427–444PubMedCrossRef Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis. Osteoporos Int 18:427–444PubMedCrossRef
9.
Zurück zum Zitat Loke YK, Cavallazzi R, Singh S (2011) Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax 66:699–708PubMedCrossRef Loke YK, Cavallazzi R, Singh S (2011) Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax 66:699–708PubMedCrossRef
10.
Zurück zum Zitat David C, Confavreux CB, Mehsen N, Paccou J, Leboime A, Legrand E (2010) Severity of osteoporosis: what is the impact of co-morbidities? Joint Bone Spine 77(Suppl 2):S103–S106PubMedCrossRef David C, Confavreux CB, Mehsen N, Paccou J, Leboime A, Legrand E (2010) Severity of osteoporosis: what is the impact of co-morbidities? Joint Bone Spine 77(Suppl 2):S103–S106PubMedCrossRef
11.
Zurück zum Zitat Bazelier MT, van Staa TP, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P, Herings RM, de Vries F (2012) Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology 78:1967–1973PubMedCrossRef Bazelier MT, van Staa TP, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P, Herings RM, de Vries F (2012) Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology 78:1967–1973PubMedCrossRef
12.
Zurück zum Zitat Dennison EM, Compston JE, Flahive J et al (2012) Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 50:1288–1293PubMedCrossRef Dennison EM, Compston JE, Flahive J et al (2012) Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 50:1288–1293PubMedCrossRef
13.
Zurück zum Zitat Cline RR, Farley JF, Hansen RA, Schommer JC (2005) Osteoporosis beliefs and antiresorptive medication use. Maturitas 50:196–208PubMedCrossRef Cline RR, Farley JF, Hansen RA, Schommer JC (2005) Osteoporosis beliefs and antiresorptive medication use. Maturitas 50:196–208PubMedCrossRef
14.
Zurück zum Zitat Gerend MA, Aiken LS, West SG, Erchull MJ (2004) Beyond medical risk: investigating the psychological factors underlying women's perceptions of susceptibility to breast cancer, heart disease, and osteoporosis. Health Psychol 23:247–258PubMedCrossRef Gerend MA, Aiken LS, West SG, Erchull MJ (2004) Beyond medical risk: investigating the psychological factors underlying women's perceptions of susceptibility to breast cancer, heart disease, and osteoporosis. Health Psychol 23:247–258PubMedCrossRef
15.
Zurück zum Zitat Cooper V, Moyle GJ, Fisher M, Reilly G, Ewan J, Liu HC, Horne R (2011) Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz. AIDS Care 23:705–713PubMedCrossRef Cooper V, Moyle GJ, Fisher M, Reilly G, Ewan J, Liu HC, Horne R (2011) Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz. AIDS Care 23:705–713PubMedCrossRef
16.
Zurück zum Zitat Horne R, Clatworthy J, Hankins M (2010) High adherence and concordance within a clinical trial of antihypertensives. Chronic Illn 6:243–251PubMedCrossRef Horne R, Clatworthy J, Hankins M (2010) High adherence and concordance within a clinical trial of antihypertensives. Chronic Illn 6:243–251PubMedCrossRef
17.
Zurück zum Zitat Kucukarslan SN (2012) A review of published studies of patients' illness perceptions and medication adherence: lessons learned and future directions. Res Social Adm Pharm 8:371–382PubMedCrossRef Kucukarslan SN (2012) A review of published studies of patients' illness perceptions and medication adherence: lessons learned and future directions. Res Social Adm Pharm 8:371–382PubMedCrossRef
18.
Zurück zum Zitat Siris ES, Gehlbach S, Adachi JD et al (2011) Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int 22:27–35PubMedCentralPubMedCrossRef Siris ES, Gehlbach S, Adachi JD et al (2011) Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int 22:27–35PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Hooven FH, Adachi JD, Adami S et al (2009) The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int 20:1107–1116PubMedCentralPubMedCrossRef Hooven FH, Adachi JD, Adami S et al (2009) The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int 20:1107–1116PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Ware JE, Kosinski M, Dewey JE (2000) How to Score Version 2 of the SF-36 Health Survey. Quality Metric, Incorporated, Lincoln, RI Ware JE, Kosinski M, Dewey JE (2000) How to Score Version 2 of the SF-36 Health Survey. Quality Metric, Incorporated, Lincoln, RI
21.
Zurück zum Zitat Gerend MA, Erchull MJ, Aiken LS, Maner JK (2006) Reasons and risk: factors underlying women's perceptions of susceptibility to osteoporosis. Maturitas 55:227–237PubMedCrossRef Gerend MA, Erchull MJ, Aiken LS, Maner JK (2006) Reasons and risk: factors underlying women's perceptions of susceptibility to osteoporosis. Maturitas 55:227–237PubMedCrossRef
22.
Zurück zum Zitat Phillipov G, Phillips PJ, Leach G, Taylor AW (1998) Public perceptions and self-reported prevalence of osteoporosis in South Australia. Osteoporos Int 8:552–556PubMedCrossRef Phillipov G, Phillips PJ, Leach G, Taylor AW (1998) Public perceptions and self-reported prevalence of osteoporosis in South Australia. Osteoporos Int 8:552–556PubMedCrossRef
23.
Zurück zum Zitat Giangregorio L, Papaioannou A, Thabane L, DeBeer J, Cranney A, Dolovich L, Adili A, Adachi JD (2008) Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskelet Disord 9:38PubMedCentralPubMedCrossRef Giangregorio L, Papaioannou A, Thabane L, DeBeer J, Cranney A, Dolovich L, Adili A, Adachi JD (2008) Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskelet Disord 9:38PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Taylor BC, Schreiner PJ, Stone KL, Fink HA, Cummings SR, Nevitt MC, Bowman PJ, Ensrud KE (2004) Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 52:1479–1486PubMedCrossRef Taylor BC, Schreiner PJ, Stone KL, Fink HA, Cummings SR, Nevitt MC, Bowman PJ, Ensrud KE (2004) Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 52:1479–1486PubMedCrossRef
25.
Zurück zum Zitat Gibson JC, Summers GD (2011) Bone health in multiple sclerosis. Osteoporos Int 22:2935–2949PubMedCrossRef Gibson JC, Summers GD (2011) Bone health in multiple sclerosis. Osteoporos Int 22:2935–2949PubMedCrossRef
26.
Zurück zum Zitat Invernizzi M, Carda S, Viscontini GS, Cisari C (2009) Osteoporosis in Parkinson's disease. Parkinsonism Relat Disord 15:339–346PubMedCrossRef Invernizzi M, Carda S, Viscontini GS, Cisari C (2009) Osteoporosis in Parkinson's disease. Parkinsonism Relat Disord 15:339–346PubMedCrossRef
28.
Zurück zum Zitat Goodin DS, Frohman EM, Garmany GP Jr, Halper J, Likosky WH, Lublin FD, Silberberg DH, Stuart WH, van den Noort S (2002) Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 58:169–178PubMedCrossRef Goodin DS, Frohman EM, Garmany GP Jr, Halper J, Likosky WH, Lublin FD, Silberberg DH, Stuart WH, van den Noort S (2002) Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 58:169–178PubMedCrossRef
29.
Zurück zum Zitat Thurman DJ, Stevens JA, Rao JK (2008) Practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 70:473–479PubMedCrossRef Thurman DJ, Stevens JA, Rao JK (2008) Practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 70:473–479PubMedCrossRef
30.
Zurück zum Zitat Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ (2010) Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74:924–931PubMedCrossRef Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ (2010) Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74:924–931PubMedCrossRef
31.
Zurück zum Zitat Grimes D, Gordon J, Snelgrove B et al (2012) Canadian guidelines on Parkinson's disease. Can J Neurol Sci 39:S1–S30PubMed Grimes D, Gordon J, Snelgrove B et al (2012) Canadian guidelines on Parkinson's disease. Can J Neurol Sci 39:S1–S30PubMed
36.
Zurück zum Zitat (2002) Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 46:328–346 (2002) Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 46:328–346
37.
Zurück zum Zitat (2003) American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 124: 791–794 (2003) American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 124: 791–794
40.
Zurück zum Zitat Mowat C, Cole A, Windsor A et al (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60:571–607PubMedCrossRef Mowat C, Cole A, Windsor A et al (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60:571–607PubMedCrossRef
44.
Zurück zum Zitat Kasje WN, Denig P, De Graeff PA, Haaijer-Ruskamp FM (2004) Physicians' views on joint treatment guidelines for primary and secondary care. Int J Qual Health Care 16:229–236PubMedCrossRef Kasje WN, Denig P, De Graeff PA, Haaijer-Ruskamp FM (2004) Physicians' views on joint treatment guidelines for primary and secondary care. Int J Qual Health Care 16:229–236PubMedCrossRef
45.
Zurück zum Zitat Kvamme OJ, Olesen F, Samuelson M (2001) Improving the interface between primary and secondary care: a statement from the European Working Party on Quality in Family Practice (EQuiP). Qual Health Care 10:33–39PubMedCentralPubMedCrossRef Kvamme OJ, Olesen F, Samuelson M (2001) Improving the interface between primary and secondary care: a statement from the European Working Party on Quality in Family Practice (EQuiP). Qual Health Care 10:33–39PubMedCentralPubMedCrossRef
46.
Zurück zum Zitat Giangregorio L, Dolovich L, Cranney A, Adili A, Debeer J, Papaioannou A, Thabane L, Adachi JD (2009) Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns 74:213–220PubMedCrossRef Giangregorio L, Dolovich L, Cranney A, Adili A, Debeer J, Papaioannou A, Thabane L, Adachi JD (2009) Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns 74:213–220PubMedCrossRef
47.
Zurück zum Zitat de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56:221–229PubMedCrossRef de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56:221–229PubMedCrossRef
48.
Zurück zum Zitat Stockwell T, Donath S, Cooper-Stanbury M, Chikritzhs T, Catalano P, Mateo C (2004) Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction 99:1024–1033PubMedCrossRef Stockwell T, Donath S, Cooper-Stanbury M, Chikritzhs T, Catalano P, Mateo C (2004) Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction 99:1024–1033PubMedCrossRef
49.
Zurück zum Zitat Hundrup YA, Høidrup S, Obel EB, Rasmussen NK (2004) The validity of self-reported fractures among Danish female nurses: comparison with fractures registered in the Danish National Hospital Register. Scandinavian Journal of Public Health 32:136–143PubMedCrossRef Hundrup YA, Høidrup S, Obel EB, Rasmussen NK (2004) The validity of self-reported fractures among Danish female nurses: comparison with fractures registered in the Danish National Hospital Register. Scandinavian Journal of Public Health 32:136–143PubMedCrossRef
50.
Zurück zum Zitat Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, Lewis CE, Kipersztok S, Borne C, Jackson RD (2004) Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials. Menopause 11:264–274PubMedCrossRef Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, Lewis CE, Kipersztok S, Borne C, Jackson RD (2004) Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials. Menopause 11:264–274PubMedCrossRef
51.
Zurück zum Zitat Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117–139PubMedCrossRef Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117–139PubMedCrossRef
52.
Zurück zum Zitat Carmona L, Villaverde V, Hernandez-Garcia C, Ballina J, Gabriel R, Laffon A (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41:88–95CrossRef Carmona L, Villaverde V, Hernandez-Garcia C, Ballina J, Gabriel R, Laffon A (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41:88–95CrossRef
53.
Zurück zum Zitat Cimmino MA, Parisi M, Moggiana G, Mela GS, Accardo S (1998) Prevalence of rheumatoid arthritis in Italy: the Chiavari Study. Ann Rheum Dis 57:315–318PubMedCrossRef Cimmino MA, Parisi M, Moggiana G, Mela GS, Accardo S (1998) Prevalence of rheumatoid arthritis in Italy: the Chiavari Study. Ann Rheum Dis 57:315–318PubMedCrossRef
54.
55.
Zurück zum Zitat Gabriel SE, Crowson CS, O'Fallon WM (1999) The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arthritis Rheum 42:415–420PubMedCrossRef Gabriel SE, Crowson CS, O'Fallon WM (1999) The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arthritis Rheum 42:415–420PubMedCrossRef
56.
Zurück zum Zitat Guo F, He D, Zhang W, Walton RG (2012) Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 60:599–606PubMedCrossRef Guo F, He D, Zhang W, Walton RG (2012) Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 60:599–606PubMedCrossRef
Metadaten
Titel
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study
verfasst von
C. L. Gregson
E. M. Dennison
J. E. Compston
S. Adami
J. D. Adachi
F. A. Anderson Jr
S. Boonen
R. Chapurlat
A. Díez-Pérez
S. L. Greenspan
F. H. Hooven
A. Z. LaCroix
J. W. Nieves
J. C. Netelenbos
J. Pfeilschifter
M. Rossini
C. Roux
K. G. Saag
S. Silverman
E. S. Siris
N. B. Watts
A. Wyman
C. Cooper
for the GLOW Investigators
Publikationsdatum
01.01.2014
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 1/2014
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-013-2438-y

Weitere Artikel der Ausgabe 1/2014

Osteoporosis International 1/2014 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.